Log in to save to my catalogue

Transcriptome analysis reveals the clinical significance of CXCL13 in Pan-Gyn tumors

Transcriptome analysis reveals the clinical significance of CXCL13 in Pan-Gyn tumors

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10923744

Transcriptome analysis reveals the clinical significance of CXCL13 in Pan-Gyn tumors

About this item

Full title

Transcriptome analysis reveals the clinical significance of CXCL13 in Pan-Gyn tumors

Publisher

Berlin/Heidelberg: Springer Berlin Heidelberg

Journal title

Journal of cancer research and clinical oncology, 2024-03, Vol.150 (3), p.116-116, Article 116

Language

English

Formats

Publication information

Publisher

Berlin/Heidelberg: Springer Berlin Heidelberg

More information

Scope and Contents

Contents

Background
Gynecologic and breast tumors (Pan-Gyn) exhibit similar characteristics, and the role of CXCL13 in anti-tumor immunity and it’s potential as a biomarker for immune checkpoint blockade (ICB) therapy have been gradually revealed. However, the precise role of CXCL13 in Pan-Gyn remains unclear, lacking a systematic analysis.
Methods

Alternative Titles

Full title

Transcriptome analysis reveals the clinical significance of CXCL13 in Pan-Gyn tumors

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10923744

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10923744

Other Identifiers

ISSN

1432-1335,0171-5216

E-ISSN

1432-1335

DOI

10.1007/s00432-024-05619-3

How to access this item